360
Participants
Start Date
February 1, 2021
Primary Completion Date
June 30, 2027
Study Completion Date
September 30, 2027
echocardiography
Full echocardiography will be performed at baseline and during the follow-up at H1, H3, H6 and H12.
Landiolol
Patients randomized to the experimental group will be treated according to the standard of care plus for 2 days with landiolol IV started at a dose of 1 microgram/kg/min and progressively increased every 10 minutes to a maximum of 40 micrograms/kg/min.
RECRUITING
CHU Amiens, Amiens
CH Dieppe
UNKNOWN
CH Elbeuf
UNKNOWN
CH Le Havre
UNKNOWN
Centre Hospitalier de Beauvais
OTHER
CH Compiègne
UNKNOWN
CH Laon
UNKNOWN
University Hospital, Caen
OTHER
CH Cherbourg
UNKNOWN
University Hospital, Lille
OTHER
CH Douai
UNKNOWN
CH Montreuil
UNKNOWN
Centre Hospitalier de Roubaix
OTHER
Centre Hospitalier de Bethune
NETWORK
CH Lomme
UNKNOWN
Centre Hospitalier de Lens
OTHER
Tourcoing Hospital
OTHER
Centre Hospitalier VALENCIENNES
OTHER
Centre Hospitalier Arras
OTHER
Hospital Ambroise Paré Paris
OTHER
University Hospital, Brest
OTHER
Henri Mondor University Hospital
OTHER
Hospital Avicenne
OTHER
University Hospital, Montpellier
OTHER
CH Calais
UNKNOWN
Hôpital Edouard Herriot
OTHER
Centre Hospitalier Universitaire de Nīmes
OTHER
Groupe Hospitalier Pitié-Salpêtrière
UNKNOWN
Hôpital Louis Mourier, Colombes
UNKNOWN
Centre Hospitalier Universitaire, Amiens
OTHER